gurkan, e. 2020. Effects of Dapagliflozin on Serum Low-Density Lipoprotein Cholesterol and Triglyceride Levels. European Journal of Therapeutics , vol.26, no.1 , 76-80.

gurkan, e., (2020). Effects of Dapagliflozin on Serum Low-Density Lipoprotein Cholesterol and Triglyceride Levels. European Journal of Therapeutics , vol.26, no.1, 76-80.

gurkan, EREN. "Effects of Dapagliflozin on Serum Low-Density Lipoprotein Cholesterol and Triglyceride Levels," European Journal of Therapeutics , vol.26, no.1, 76-80, 2020

gurkan, EREN. "Effects of Dapagliflozin on Serum Low-Density Lipoprotein Cholesterol and Triglyceride Levels." European Journal of Therapeutics , vol.26, no.1, pp.76-80, 2020

gurkan, e. (2020) . "Effects of Dapagliflozin on Serum Low-Density Lipoprotein Cholesterol and Triglyceride Levels." European Journal of Therapeutics , vol.26, no.1, pp.76-80.

@article{article, author={EREN GÜRKAN}, title={Effects of Dapagliflozin on Serum Low-Density Lipoprotein Cholesterol and Triglyceride Levels}, journal={European Journal of Therapeutics}, year=2020, pages={76-80} }